Refresh
Company Event • 01 Nov 2021 15:00 • Latest
Location:Japan
Q2 FY2021 (ending March 31, 2022) Financial Disclosure Meeting
Speakers
- Haruo Naito (Director, Representative Corporate Officer and CEO, Eisai Co., Ltd.)
- Ivan Cheung (Senior Vice President President, Neurology Business Group Global Alzheimer's Disease Officer, Eisai Co., Ltd.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
Company Event • 12 May 2021 15:00
Location:Japan
Financial Results Briefing for the Fiscal Year Ended March 2021
Speakers
- Haruo Naito (Director, Representative Corporate Officer and CEO, Eisai Co., Ltd.)
- Ryohei Yanagi (Executive Vice President, CFO, Eisai Co., Ltd.)
- Ivan Cheung (Senior Vice President and President of Neurology Business Group, Eisai Co., Ltd.)
- Takashi Owa (Vice President, Chief Medicine Creation Officer, Oncology Business Group Chief Discovery Officer, Oncology Business Group, Eisai Co., Ltd.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
Duration
- Presentation: 17 minutes
- Q&A: 17 minutes
Company Event • 26 Mar 2021 15:00
Location:Japan
FY2020 Eisai Information Meeting
Speakers
- Haruo Naito (Director, Representative Corporate Officer and CEO, Eisai Co., Ltd.)
- Ryohei Yanagi (Executive Vice President, CFO, Eisai Co., Ltd.)
- Ivan Cheung (Senior Vice President and President of Neurology Business Group, Eisai Co., Ltd.)
- Kazumasa Nagayama (Vice President, Chief Strategy Officer, Eisai Co., Ltd.)
- Keisuke Naito (Vice President, Chief Digital Officer, Head of Consumer Experience Transformation HQs, Deputy President, Eisai Japan, Eisai Co., Ltd.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Hyogo (Analyst, Mitsubishi UFJ Trust and Banking Corporation)
- Otomo (Analyst, Sumitomo Mitsui DS Asset Management Company, Limited)
- Koguchi (Analyst, Sumitomo Mitsui Trust Asset Management Co., Ltd.)
Duration
- Presentation: 55 minutes
- Q&A: 55 minutes
Company Event • 13 May 2020 15:30
Location:Japan
Financial Results Briefing for the Fiscal Year Ended March 2020
Speakers
- Haruo Naito (Director, Representative Corporate Officer and CEO, Eisai Co., Ltd.)
- Ivan Cheung (Senior Vice President and President of Neurology Business Group, Eisai Co., Ltd.)
- Takashi Owa (Vice President and Chief Medicine Creation Officer of Oncology Business Group, Eisai Co., Ltd.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
Company Event • 06 Mar 2020 15:00
Location:4-6-10 Koishikawa
Bunkyo-ku
Japan
FY2019 Eisai Information Meeting
Speakers
- Haruo Naito (Director, Representative Corporate Officer and CEO, Eisai Co., Ltd.)
- Takashi Owa (Vice President and Chief of Medicine Creation Officer of Oncology Business Group, Eisai Co., Ltd.)
- Masanori Tsuno (Senior Executive Officer and Deputy Chief of Medicine Creation Officer of Neurology Business Group, Eisai Co., Ltd.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
Duration
- Presentation: 23 minutes
- Q&A: 23 minutes